BROOK H BYERS
CIK 1032454 · last filed 2016-07-06
BROOK H BYERS is a corporate insider who has filed 29 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for CDNA, was dated Jul 6, 2016. Across all open-market trades the lifetime net is +$533.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $207.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$207.84M
5
29
$533.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CDNA | Director | 773,086 | $25.06 | $19.37M | $533.0K | 10 | 2016-07-06 |
| PACB | Director | 110,504 | $1.32 | $145.9K | $0 | 8 | 2016-05-19 |
| Foundation Medicine, Inc. (FMI) Delisted | Director | 165 | — | — | $0 | 3 | 2015-04-14 |
| VCYT | Director | 3,551,929 | $53.02 | $188.32M | $0 | 1 | 2013-11-04 |
| GENOMIC HEALTH INC (GHDX) Delisted | Director | 24,357 | — | — | $0 | 6 | 2011-04-05 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-07-06 | CDNA | Grant (A) | +2,098 | $0 | EDGAR |
| 2016-05-19 | PACB | Grant (A) | — | $0 | EDGAR |
| 2016-04-26 | PACB | Other (J) | −1,646,304 | $0 | EDGAR |
| 2016-04-05 | CDNA | Grant (A) | +2,247 | $0 | EDGAR |
| 2016-01-05 | CDNA | Grant (A) | +2,112 | $0 | EDGAR |
| 2015-11-20 | PACB | Other (J) | −969,923 | $0 | EDGAR |
| 2015-11-13 | PACB | Other (J) | −969,923 | $0 | EDGAR |
| 2015-10-05 | CDNA | Grant (A) | +1,739 | $0 | EDGAR |
| 2015-07-06 | CDNA | Grant (A) | +2,117 | $0 | EDGAR |
| 2015-06-17 | CDNA | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.